China’s drug‑and‑device regulator announced that 42 breakthrough medical devices received approval for sale between January and June, marking a surge of high‑tech tools for patients at home and abroad. The approvals are part of a larger batch of 1,595 Class III devices – the most tightly regulated group, which includes implants, life‑support machines and advanced imaging tools. What makes these 42 stand out is that several are world‑firsts. One is an implantable brain‑computer interface that can read brain signals and transmit them wirelessly, a technology previously only seen in research labs. Another is a biodegradable heart‑defect plug that dissolves on its own after sealing a hole in the atrial septum, eliminating the need for permanent metal devices. Regulators say the new “green channel” fast‑track is speeding up review of cutting‑edge products such as donor organ‑perfusion systems and ultra‑high‑dose radiation machines. By championing home‑grown inventions, China aims to meet local patients’ needs while offering fresh solutions to the global market. The wave of approvals signals a rapid shift toward more sophisticated, home‑grown medical technology that could reshape treatment options worldwide.
Read more